Skip to main content

CMV

2
Pipeline Programs
5
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 6 programs with unclassified modality

Competitive Landscape

5 companies ranked by most advanced pipeline stage

MSD
MSDIreland - Ballydine
2 programs
1
Letermovir PillPhase 21 trial
Real time PCRN/A1 trial
Active Trials
NCT04280380Unknown400Est. Dec 2022
NCT04017962Completed102Est. Jul 2025
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
2 programs
1
Letermovir PillPhase 2
Real time PCRN/A
QIAGEN
QIAGENGermany - Hilden
1 program
QuantiFERON CMV AssayN/A1 trial
Active Trials
NCT03502161Terminated8Est. Jun 2020
Merck & Co.
Merck & Co.RAHWAY, NJ
1 program
Real time PCRN/A
Jazz Pharmaceuticals
Jazz PharmaceuticalsCA - Palo Alto
1 program
BrincidofovirPHASE_3Small Molecule1 trial
Active Trials
NCT01769170Completed452Est. Jan 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Jazz PharmaceuticalsBrincidofovir
MSDLetermovir Pill
MSDReal time PCR
QIAGENQuantiFERON CMV Assay

Clinical Trials (4)

Total enrollment: 962 patients across 4 trials

NCT01769170Jazz PharmaceuticalsBrincidofovir

A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients

Start: Aug 2013Est. completion: Jan 2016452 patients
Phase 3Completed
NCT04017962MSDLetermovir Pill

A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection

Start: Jul 2019Est. completion: Jul 2025102 patients
Phase 2Completed
NCT04280380MSDReal time PCR

Cytomegalovirus Infection in Critically Ill Patients and Patients Receiving Anticancer Therapy

Start: Mar 2020Est. completion: Dec 2022400 patients
N/AUnknown
NCT03502161QIAGENQuantiFERON CMV Assay

Clinical Evaluation of the QuantiFERON CMV Assay

Start: Nov 2018Est. completion: Jun 20208 patients
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.